Special Issue "Cardiomyopathy and Vasculopathy: From Molecular Basis to Advanced Therapy"
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 8080
2. Department of Pediatrics, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
3. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
Interests: vascular biology; congenital heart disease; heart failure; ductus arteriosus
Even with the advances of clinical medicine, cardiovascular disease remains the leading cause of morbidity and mortality in the modern era. Thus, both basic and clinical research for novel mechanisms and therapy of cardiomyopathy and vasculopathy are still needed, to elucidate molecular pathogenesis or therapeutic targets and to reduce mortality and improve the life quality.
To this end, this Special Issue of Biomedicines has as its main objective to gather articles that have a basic research background, a clear translational potential, and clinical applications. Therefore, studies investigating novel molecular mechanisms of cardiovascular diseases, preclinical translational research, and clinical management that can shed some light to this important field are welcome in this Special Issue.
In this Special Issue, we cordially invite researchers as well as clinicians to submit their invaluable studies on cardiovascular disease of children and adults, from bench or bedside. Therefore, original investigations and review articles are welcome.
In conclusion, this Special Issue is to underscore the key importance of both basic and cardiovascular research. Potential topics include but are not limited to the following:
- Congenital heart disease
- Biomarkers for cardiovascular disease
- Myocardial infarction
- Heart failure
- Cardiac arrhythmias
- Pulmonary vascular disease
- Peripheral artery disease
Dr. Jonghau Hsu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vascular biology
- heart failure
- congenital heart disease
- pulmonary hypertension